nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—Capecitabine—stomach cancer	0.0455	0.415	CbGbCtD
Sitaxentan—CYP2C9—Fluorouracil—stomach cancer	0.027	0.246	CbGbCtD
Sitaxentan—CYP3A4—Irinotecan—stomach cancer	0.0163	0.149	CbGbCtD
Sitaxentan—CYP3A4—Docetaxel—stomach cancer	0.012	0.109	CbGbCtD
Sitaxentan—CYP3A4—Doxorubicin—stomach cancer	0.00892	0.0814	CbGbCtD
Sitaxentan—Epistaxis—Epirubicin—stomach cancer	0.000248	0.000375	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—stomach cancer	0.000247	0.000374	CcSEcCtD
Sitaxentan—Infection—Docetaxel—stomach cancer	0.000247	0.000374	CcSEcCtD
Sitaxentan—Weight decreased—Doxorubicin—stomach cancer	0.000247	0.000374	CcSEcCtD
Sitaxentan—Sinusitis—Epirubicin—stomach cancer	0.000246	0.000373	CcSEcCtD
Sitaxentan—Hyperglycaemia—Doxorubicin—stomach cancer	0.000246	0.000373	CcSEcCtD
Sitaxentan—Diarrhoea—Irinotecan—stomach cancer	0.000246	0.000373	CcSEcCtD
Sitaxentan—Dry mouth—Capecitabine—stomach cancer	0.000245	0.000372	CcSEcCtD
Sitaxentan—Nervous system disorder—Docetaxel—stomach cancer	0.000244	0.000369	CcSEcCtD
Sitaxentan—Thrombocytopenia—Docetaxel—stomach cancer	0.000243	0.000369	CcSEcCtD
Sitaxentan—Infestation NOS—Doxorubicin—stomach cancer	0.000243	0.000368	CcSEcCtD
Sitaxentan—Infestation—Doxorubicin—stomach cancer	0.000243	0.000368	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—stomach cancer	0.000243	0.000368	CcSEcCtD
Sitaxentan—Confusional state—Capecitabine—stomach cancer	0.000243	0.000367	CcSEcCtD
Sitaxentan—Tachycardia—Docetaxel—stomach cancer	0.000242	0.000367	CcSEcCtD
Sitaxentan—Skin disorder—Docetaxel—stomach cancer	0.000241	0.000366	CcSEcCtD
Sitaxentan—Oedema—Capecitabine—stomach cancer	0.000241	0.000364	CcSEcCtD
Sitaxentan—Bradycardia—Epirubicin—stomach cancer	0.00024	0.000364	CcSEcCtD
Sitaxentan—Renal failure—Doxorubicin—stomach cancer	0.000239	0.000362	CcSEcCtD
Sitaxentan—Infection—Capecitabine—stomach cancer	0.000239	0.000362	CcSEcCtD
Sitaxentan—Dizziness—Irinotecan—stomach cancer	0.000238	0.00036	CcSEcCtD
Sitaxentan—Haemoglobin—Epirubicin—stomach cancer	0.000237	0.000359	CcSEcCtD
Sitaxentan—Jaundice—Doxorubicin—stomach cancer	0.000237	0.000359	CcSEcCtD
Sitaxentan—Stomatitis—Doxorubicin—stomach cancer	0.000237	0.000359	CcSEcCtD
Sitaxentan—Anorexia—Docetaxel—stomach cancer	0.000237	0.000359	CcSEcCtD
Sitaxentan—Rhinitis—Epirubicin—stomach cancer	0.000236	0.000358	CcSEcCtD
Sitaxentan—Conjunctivitis—Doxorubicin—stomach cancer	0.000236	0.000358	CcSEcCtD
Sitaxentan—Nervous system disorder—Capecitabine—stomach cancer	0.000236	0.000357	CcSEcCtD
Sitaxentan—Haemorrhage—Epirubicin—stomach cancer	0.000236	0.000357	CcSEcCtD
Sitaxentan—Hepatitis—Epirubicin—stomach cancer	0.000236	0.000357	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—stomach cancer	0.000236	0.000357	CcSEcCtD
Sitaxentan—Diarrhoea—Fluorouracil—stomach cancer	0.000236	0.000357	CcSEcCtD
Sitaxentan—Thrombocytopenia—Capecitabine—stomach cancer	0.000235	0.000357	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—stomach cancer	0.000235	0.000356	CcSEcCtD
Sitaxentan—Tachycardia—Capecitabine—stomach cancer	0.000235	0.000356	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—stomach cancer	0.000234	0.000354	CcSEcCtD
Sitaxentan—Skin disorder—Capecitabine—stomach cancer	0.000234	0.000354	CcSEcCtD
Sitaxentan—Urinary tract disorder—Epirubicin—stomach cancer	0.000233	0.000353	CcSEcCtD
Sitaxentan—Oedema peripheral—Epirubicin—stomach cancer	0.000232	0.000352	CcSEcCtD
Sitaxentan—Hypotension—Docetaxel—stomach cancer	0.000232	0.000352	CcSEcCtD
Sitaxentan—Haematuria—Doxorubicin—stomach cancer	0.000232	0.000351	CcSEcCtD
Sitaxentan—Urethral disorder—Epirubicin—stomach cancer	0.000231	0.00035	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00023	0.000348	CcSEcCtD
Sitaxentan—Epistaxis—Doxorubicin—stomach cancer	0.000229	0.000347	CcSEcCtD
Sitaxentan—Anorexia—Capecitabine—stomach cancer	0.000229	0.000347	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—stomach cancer	0.000229	0.000346	CcSEcCtD
Sitaxentan—Vomiting—Irinotecan—stomach cancer	0.000228	0.000346	CcSEcCtD
Sitaxentan—Sinusitis—Doxorubicin—stomach cancer	0.000228	0.000346	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—stomach cancer	0.000228	0.000345	CcSEcCtD
Sitaxentan—Dizziness—Fluorouracil—stomach cancer	0.000228	0.000345	CcSEcCtD
Sitaxentan—Visual impairment—Epirubicin—stomach cancer	0.000227	0.000344	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—stomach cancer	0.000227	0.000344	CcSEcCtD
Sitaxentan—Rash—Irinotecan—stomach cancer	0.000227	0.000343	CcSEcCtD
Sitaxentan—Dermatitis—Irinotecan—stomach cancer	0.000226	0.000343	CcSEcCtD
Sitaxentan—Headache—Irinotecan—stomach cancer	0.000225	0.000341	CcSEcCtD
Sitaxentan—Hypotension—Capecitabine—stomach cancer	0.000225	0.000341	CcSEcCtD
Sitaxentan—Insomnia—Docetaxel—stomach cancer	0.000225	0.00034	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—stomach cancer	0.000223	0.000337	CcSEcCtD
Sitaxentan—Bradycardia—Doxorubicin—stomach cancer	0.000222	0.000337	CcSEcCtD
Sitaxentan—Somnolence—Docetaxel—stomach cancer	0.000221	0.000335	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—stomach cancer	0.000221	0.000335	CcSEcCtD
Sitaxentan—Eye disorder—Epirubicin—stomach cancer	0.00022	0.000334	CcSEcCtD
Sitaxentan—Tinnitus—Epirubicin—stomach cancer	0.00022	0.000333	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—stomach cancer	0.000219	0.000332	CcSEcCtD
Sitaxentan—Haemoglobin—Doxorubicin—stomach cancer	0.000219	0.000332	CcSEcCtD
Sitaxentan—Flushing—Epirubicin—stomach cancer	0.000219	0.000332	CcSEcCtD
Sitaxentan—Cardiac disorder—Epirubicin—stomach cancer	0.000219	0.000332	CcSEcCtD
Sitaxentan—Vomiting—Fluorouracil—stomach cancer	0.000219	0.000332	CcSEcCtD
Sitaxentan—Rhinitis—Doxorubicin—stomach cancer	0.000219	0.000331	CcSEcCtD
Sitaxentan—Dyspepsia—Docetaxel—stomach cancer	0.000219	0.000331	CcSEcCtD
Sitaxentan—Haemorrhage—Doxorubicin—stomach cancer	0.000218	0.000331	CcSEcCtD
Sitaxentan—Hepatitis—Doxorubicin—stomach cancer	0.000218	0.000331	CcSEcCtD
Sitaxentan—Insomnia—Capecitabine—stomach cancer	0.000218	0.00033	CcSEcCtD
Sitaxentan—Rash—Fluorouracil—stomach cancer	0.000217	0.000329	CcSEcCtD
Sitaxentan—Dermatitis—Fluorouracil—stomach cancer	0.000217	0.000328	CcSEcCtD
Sitaxentan—Decreased appetite—Docetaxel—stomach cancer	0.000216	0.000327	CcSEcCtD
Sitaxentan—Headache—Fluorouracil—stomach cancer	0.000216	0.000327	CcSEcCtD
Sitaxentan—Urinary tract disorder—Doxorubicin—stomach cancer	0.000216	0.000327	CcSEcCtD
Sitaxentan—Oedema peripheral—Doxorubicin—stomach cancer	0.000215	0.000326	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000214	0.000325	CcSEcCtD
Sitaxentan—Fatigue—Docetaxel—stomach cancer	0.000214	0.000325	CcSEcCtD
Sitaxentan—Angiopathy—Epirubicin—stomach cancer	0.000214	0.000324	CcSEcCtD
Sitaxentan—Urethral disorder—Doxorubicin—stomach cancer	0.000214	0.000324	CcSEcCtD
Sitaxentan—Nausea—Irinotecan—stomach cancer	0.000213	0.000323	CcSEcCtD
Sitaxentan—Immune system disorder—Epirubicin—stomach cancer	0.000213	0.000323	CcSEcCtD
Sitaxentan—Mediastinal disorder—Epirubicin—stomach cancer	0.000213	0.000322	CcSEcCtD
Sitaxentan—Pain—Docetaxel—stomach cancer	0.000212	0.000322	CcSEcCtD
Sitaxentan—Constipation—Docetaxel—stomach cancer	0.000212	0.000322	CcSEcCtD
Sitaxentan—Dyspepsia—Capecitabine—stomach cancer	0.000212	0.000321	CcSEcCtD
Sitaxentan—Visual impairment—Doxorubicin—stomach cancer	0.00021	0.000319	CcSEcCtD
Sitaxentan—Decreased appetite—Capecitabine—stomach cancer	0.000209	0.000317	CcSEcCtD
Sitaxentan—Alopecia—Epirubicin—stomach cancer	0.000208	0.000316	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000208	0.000315	CcSEcCtD
Sitaxentan—Fatigue—Capecitabine—stomach cancer	0.000207	0.000314	CcSEcCtD
Sitaxentan—Mental disorder—Epirubicin—stomach cancer	0.000207	0.000313	CcSEcCtD
Sitaxentan—Pain—Capecitabine—stomach cancer	0.000206	0.000312	CcSEcCtD
Sitaxentan—Constipation—Capecitabine—stomach cancer	0.000206	0.000312	CcSEcCtD
Sitaxentan—Malnutrition—Epirubicin—stomach cancer	0.000205	0.000311	CcSEcCtD
Sitaxentan—Feeling abnormal—Docetaxel—stomach cancer	0.000205	0.00031	CcSEcCtD
Sitaxentan—Nausea—Fluorouracil—stomach cancer	0.000204	0.00031	CcSEcCtD
Sitaxentan—Eye disorder—Doxorubicin—stomach cancer	0.000204	0.000309	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—stomach cancer	0.000204	0.000308	CcSEcCtD
Sitaxentan—Tinnitus—Doxorubicin—stomach cancer	0.000203	0.000308	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—stomach cancer	0.000203	0.000307	CcSEcCtD
Sitaxentan—Cardiac disorder—Doxorubicin—stomach cancer	0.000203	0.000307	CcSEcCtD
Sitaxentan—Flushing—Doxorubicin—stomach cancer	0.000203	0.000307	CcSEcCtD
Sitaxentan—Tension—Epirubicin—stomach cancer	0.000201	0.000305	CcSEcCtD
Sitaxentan—Nervousness—Epirubicin—stomach cancer	0.000199	0.000302	CcSEcCtD
Sitaxentan—Feeling abnormal—Capecitabine—stomach cancer	0.000198	0.0003	CcSEcCtD
Sitaxentan—Angiopathy—Doxorubicin—stomach cancer	0.000198	0.0003	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—stomach cancer	0.000198	0.0003	CcSEcCtD
Sitaxentan—Muscle spasms—Epirubicin—stomach cancer	0.000197	0.000299	CcSEcCtD
Sitaxentan—Immune system disorder—Doxorubicin—stomach cancer	0.000197	0.000299	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—stomach cancer	0.000197	0.000299	CcSEcCtD
Sitaxentan—Mediastinal disorder—Doxorubicin—stomach cancer	0.000197	0.000298	CcSEcCtD
Sitaxentan—Body temperature increased—Docetaxel—stomach cancer	0.000196	0.000298	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—stomach cancer	0.000196	0.000298	CcSEcCtD
Sitaxentan—Alopecia—Doxorubicin—stomach cancer	0.000193	0.000292	CcSEcCtD
Sitaxentan—Mental disorder—Doxorubicin—stomach cancer	0.000191	0.00029	CcSEcCtD
Sitaxentan—Urticaria—Capecitabine—stomach cancer	0.000191	0.000289	CcSEcCtD
Sitaxentan—Ill-defined disorder—Epirubicin—stomach cancer	0.00019	0.000289	CcSEcCtD
Sitaxentan—Body temperature increased—Capecitabine—stomach cancer	0.00019	0.000288	CcSEcCtD
Sitaxentan—Malnutrition—Doxorubicin—stomach cancer	0.00019	0.000288	CcSEcCtD
Sitaxentan—Anaemia—Epirubicin—stomach cancer	0.00019	0.000288	CcSEcCtD
Sitaxentan—Agitation—Epirubicin—stomach cancer	0.000189	0.000286	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—stomach cancer	0.000187	0.000283	CcSEcCtD
Sitaxentan—Tension—Doxorubicin—stomach cancer	0.000186	0.000282	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000185	0.000281	CcSEcCtD
Sitaxentan—Malaise—Epirubicin—stomach cancer	0.000185	0.000281	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—stomach cancer	0.000185	0.00028	CcSEcCtD
Sitaxentan—Nervousness—Doxorubicin—stomach cancer	0.000185	0.00028	CcSEcCtD
Sitaxentan—Vertigo—Epirubicin—stomach cancer	0.000184	0.000279	CcSEcCtD
Sitaxentan—Leukopenia—Epirubicin—stomach cancer	0.000184	0.000278	CcSEcCtD
Sitaxentan—Hypersensitivity—Docetaxel—stomach cancer	0.000183	0.000277	CcSEcCtD
Sitaxentan—Muscle spasms—Doxorubicin—stomach cancer	0.000183	0.000277	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—stomach cancer	0.000181	0.000274	CcSEcCtD
Sitaxentan—Asthenia—Docetaxel—stomach cancer	0.000178	0.00027	CcSEcCtD
Sitaxentan—Infection—Methotrexate—stomach cancer	0.000178	0.00027	CcSEcCtD
Sitaxentan—Hypersensitivity—Capecitabine—stomach cancer	0.000177	0.000268	CcSEcCtD
Sitaxentan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000176	0.000267	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—stomach cancer	0.000176	0.000266	CcSEcCtD
Sitaxentan—Anaemia—Doxorubicin—stomach cancer	0.000176	0.000266	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—stomach cancer	0.000175	0.000266	CcSEcCtD
Sitaxentan—Chest pain—Epirubicin—stomach cancer	0.000175	0.000265	CcSEcCtD
Sitaxentan—Agitation—Doxorubicin—stomach cancer	0.000175	0.000264	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—stomach cancer	0.000174	0.000263	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000174	0.000263	CcSEcCtD
Sitaxentan—Discomfort—Epirubicin—stomach cancer	0.000173	0.000262	CcSEcCtD
Sitaxentan—Asthenia—Capecitabine—stomach cancer	0.000173	0.000261	CcSEcCtD
Sitaxentan—Malaise—Doxorubicin—stomach cancer	0.000171	0.00026	CcSEcCtD
Sitaxentan—Dry mouth—Epirubicin—stomach cancer	0.000171	0.000259	CcSEcCtD
Sitaxentan—Vertigo—Doxorubicin—stomach cancer	0.000171	0.000259	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—stomach cancer	0.000171	0.000259	CcSEcCtD
Sitaxentan—Leukopenia—Doxorubicin—stomach cancer	0.00017	0.000258	CcSEcCtD
Sitaxentan—Diarrhoea—Docetaxel—stomach cancer	0.00017	0.000258	CcSEcCtD
Sitaxentan—Confusional state—Epirubicin—stomach cancer	0.000169	0.000256	CcSEcCtD
Sitaxentan—Oedema—Epirubicin—stomach cancer	0.000168	0.000254	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—stomach cancer	0.000167	0.000253	CcSEcCtD
Sitaxentan—Infection—Epirubicin—stomach cancer	0.000166	0.000252	CcSEcCtD
Sitaxentan—Diarrhoea—Capecitabine—stomach cancer	0.000165	0.000249	CcSEcCtD
Sitaxentan—Nervous system disorder—Epirubicin—stomach cancer	0.000164	0.000249	CcSEcCtD
Sitaxentan—Dizziness—Docetaxel—stomach cancer	0.000164	0.000249	CcSEcCtD
Sitaxentan—Thrombocytopenia—Epirubicin—stomach cancer	0.000164	0.000249	CcSEcCtD
Sitaxentan—Tachycardia—Epirubicin—stomach cancer	0.000164	0.000248	CcSEcCtD
Sitaxentan—Skin disorder—Epirubicin—stomach cancer	0.000163	0.000247	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—stomach cancer	0.000162	0.000245	CcSEcCtD
Sitaxentan—Chest pain—Doxorubicin—stomach cancer	0.000162	0.000245	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000161	0.000243	CcSEcCtD
Sitaxentan—Discomfort—Doxorubicin—stomach cancer	0.00016	0.000242	CcSEcCtD
Sitaxentan—Anorexia—Epirubicin—stomach cancer	0.00016	0.000242	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—stomach cancer	0.000159	0.000241	CcSEcCtD
Sitaxentan—Dizziness—Capecitabine—stomach cancer	0.000159	0.000241	CcSEcCtD
Sitaxentan—Dry mouth—Doxorubicin—stomach cancer	0.000158	0.00024	CcSEcCtD
Sitaxentan—Vomiting—Docetaxel—stomach cancer	0.000158	0.000239	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—stomach cancer	0.000158	0.000239	CcSEcCtD
Sitaxentan—Rash—Docetaxel—stomach cancer	0.000157	0.000237	CcSEcCtD
Sitaxentan—Hypotension—Epirubicin—stomach cancer	0.000157	0.000237	CcSEcCtD
Sitaxentan—Dermatitis—Docetaxel—stomach cancer	0.000156	0.000237	CcSEcCtD
Sitaxentan—Confusional state—Doxorubicin—stomach cancer	0.000156	0.000237	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—stomach cancer	0.000156	0.000236	CcSEcCtD
Sitaxentan—Headache—Docetaxel—stomach cancer	0.000156	0.000236	CcSEcCtD
Sitaxentan—Oedema—Doxorubicin—stomach cancer	0.000155	0.000235	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000155	0.000234	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—stomach cancer	0.000154	0.000234	CcSEcCtD
Sitaxentan—Infection—Doxorubicin—stomach cancer	0.000154	0.000233	CcSEcCtD
Sitaxentan—Pain—Methotrexate—stomach cancer	0.000153	0.000232	CcSEcCtD
Sitaxentan—Vomiting—Capecitabine—stomach cancer	0.000153	0.000232	CcSEcCtD
Sitaxentan—Nervous system disorder—Doxorubicin—stomach cancer	0.000152	0.00023	CcSEcCtD
Sitaxentan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000152	0.00023	CcSEcCtD
Sitaxentan—Rash—Capecitabine—stomach cancer	0.000152	0.00023	CcSEcCtD
Sitaxentan—Insomnia—Epirubicin—stomach cancer	0.000152	0.00023	CcSEcCtD
Sitaxentan—Dermatitis—Capecitabine—stomach cancer	0.000152	0.00023	CcSEcCtD
Sitaxentan—Tachycardia—Doxorubicin—stomach cancer	0.000151	0.000229	CcSEcCtD
Sitaxentan—Headache—Capecitabine—stomach cancer	0.000151	0.000228	CcSEcCtD
Sitaxentan—Skin disorder—Doxorubicin—stomach cancer	0.000151	0.000228	CcSEcCtD
Sitaxentan—Somnolence—Epirubicin—stomach cancer	0.000149	0.000226	CcSEcCtD
Sitaxentan—Anorexia—Doxorubicin—stomach cancer	0.000148	0.000224	CcSEcCtD
Sitaxentan—Nausea—Docetaxel—stomach cancer	0.000148	0.000224	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—stomach cancer	0.000148	0.000224	CcSEcCtD
Sitaxentan—Dyspepsia—Epirubicin—stomach cancer	0.000147	0.000223	CcSEcCtD
Sitaxentan—Decreased appetite—Epirubicin—stomach cancer	0.000146	0.000221	CcSEcCtD
Sitaxentan—Hypotension—Doxorubicin—stomach cancer	0.000145	0.000219	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000145	0.000219	CcSEcCtD
Sitaxentan—Fatigue—Epirubicin—stomach cancer	0.000144	0.000219	CcSEcCtD
Sitaxentan—Pain—Epirubicin—stomach cancer	0.000143	0.000217	CcSEcCtD
Sitaxentan—Constipation—Epirubicin—stomach cancer	0.000143	0.000217	CcSEcCtD
Sitaxentan—Nausea—Capecitabine—stomach cancer	0.000143	0.000216	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—stomach cancer	0.000142	0.000216	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—stomach cancer	0.000142	0.000214	CcSEcCtD
Sitaxentan—Insomnia—Doxorubicin—stomach cancer	0.00014	0.000212	CcSEcCtD
Sitaxentan—Feeling abnormal—Epirubicin—stomach cancer	0.000138	0.000209	CcSEcCtD
Sitaxentan—Somnolence—Doxorubicin—stomach cancer	0.000138	0.000209	CcSEcCtD
Sitaxentan—Dyspepsia—Doxorubicin—stomach cancer	0.000136	0.000207	CcSEcCtD
Sitaxentan—Decreased appetite—Doxorubicin—stomach cancer	0.000135	0.000204	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000134	0.000203	CcSEcCtD
Sitaxentan—Fatigue—Doxorubicin—stomach cancer	0.000134	0.000203	CcSEcCtD
Sitaxentan—Urticaria—Epirubicin—stomach cancer	0.000133	0.000202	CcSEcCtD
Sitaxentan—Pain—Doxorubicin—stomach cancer	0.000133	0.000201	CcSEcCtD
Sitaxentan—Constipation—Doxorubicin—stomach cancer	0.000133	0.000201	CcSEcCtD
Sitaxentan—Body temperature increased—Epirubicin—stomach cancer	0.000132	0.000201	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—stomach cancer	0.000132	0.0002	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—stomach cancer	0.000128	0.000195	CcSEcCtD
Sitaxentan—Feeling abnormal—Doxorubicin—stomach cancer	0.000128	0.000194	CcSEcCtD
Sitaxentan—Hypersensitivity—Epirubicin—stomach cancer	0.000123	0.000187	CcSEcCtD
Sitaxentan—Urticaria—Doxorubicin—stomach cancer	0.000123	0.000187	CcSEcCtD
Sitaxentan—Body temperature increased—Doxorubicin—stomach cancer	0.000123	0.000186	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—stomach cancer	0.000123	0.000186	CcSEcCtD
Sitaxentan—Asthenia—Epirubicin—stomach cancer	0.00012	0.000182	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—stomach cancer	0.000118	0.000179	CcSEcCtD
Sitaxentan—Diarrhoea—Epirubicin—stomach cancer	0.000115	0.000174	CcSEcCtD
Sitaxentan—Hypersensitivity—Doxorubicin—stomach cancer	0.000114	0.000173	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—stomach cancer	0.000114	0.000172	CcSEcCtD
Sitaxentan—Rash—Methotrexate—stomach cancer	0.000113	0.000171	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—stomach cancer	0.000113	0.000171	CcSEcCtD
Sitaxentan—Headache—Methotrexate—stomach cancer	0.000112	0.00017	CcSEcCtD
Sitaxentan—Asthenia—Doxorubicin—stomach cancer	0.000111	0.000169	CcSEcCtD
Sitaxentan—Dizziness—Epirubicin—stomach cancer	0.000111	0.000168	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL8—stomach cancer	0.000108	0.000469	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—FGFR2—stomach cancer	0.000107	0.000466	CbGpPWpGaD
Sitaxentan—Vomiting—Epirubicin—stomach cancer	0.000107	0.000161	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—stomach cancer	0.000106	0.000161	CcSEcCtD
Sitaxentan—Diarrhoea—Doxorubicin—stomach cancer	0.000106	0.000161	CcSEcCtD
Sitaxentan—Rash—Epirubicin—stomach cancer	0.000106	0.00016	CcSEcCtD
Sitaxentan—Dermatitis—Epirubicin—stomach cancer	0.000106	0.00016	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—SUCLG1—stomach cancer	0.000105	0.000457	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—IDH3B—stomach cancer	0.000105	0.000457	CbGpPWpGaD
Sitaxentan—Headache—Epirubicin—stomach cancer	0.000105	0.000159	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism—GMPR2—stomach cancer	0.000105	0.000455	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HBEGF—stomach cancer	0.000103	0.000445	CbGpPWpGaD
Sitaxentan—Dizziness—Doxorubicin—stomach cancer	0.000103	0.000155	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000101	0.00044	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.0001	0.000434	CbGpPWpGaD
Sitaxentan—Nausea—Epirubicin—stomach cancer	9.95e-05	0.000151	CcSEcCtD
Sitaxentan—Vomiting—Doxorubicin—stomach cancer	9.86e-05	0.000149	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—IRS2—stomach cancer	9.82e-05	0.000426	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NDUFS1—stomach cancer	9.78e-05	0.000425	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NDUFV1—stomach cancer	9.78e-05	0.000425	CbGpPWpGaD
Sitaxentan—Rash—Doxorubicin—stomach cancer	9.78e-05	0.000148	CcSEcCtD
Sitaxentan—Dermatitis—Doxorubicin—stomach cancer	9.77e-05	0.000148	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—IL6R—stomach cancer	9.76e-05	0.000424	CbGpPWpGaD
Sitaxentan—Headache—Doxorubicin—stomach cancer	9.71e-05	0.000147	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—RHOA—stomach cancer	9.71e-05	0.000421	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SUCLG1—stomach cancer	9.59e-05	0.000416	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—IDH3B—stomach cancer	9.59e-05	0.000416	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	9.56e-05	0.000415	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CAV1—stomach cancer	9.52e-05	0.000413	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APOA1—stomach cancer	9.5e-05	0.000412	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRB2—stomach cancer	9.46e-05	0.000411	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PPP2R1A—stomach cancer	9.27e-05	0.000403	CbGpPWpGaD
Sitaxentan—Nausea—Doxorubicin—stomach cancer	9.21e-05	0.00014	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PRKCB—stomach cancer	9.06e-05	0.000394	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6ST—stomach cancer	9.03e-05	0.000392	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	9.03e-05	0.000392	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NDUFV1—stomach cancer	8.92e-05	0.000387	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NDUFS1—stomach cancer	8.92e-05	0.000387	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	8.9e-05	0.000387	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—RHOA—stomach cancer	8.81e-05	0.000383	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PGLS—stomach cancer	8.72e-05	0.000378	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BLVRB—stomach cancer	8.72e-05	0.000378	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.72e-05	0.000378	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APC—stomach cancer	8.67e-05	0.000377	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SMAD4—stomach cancer	8.61e-05	0.000374	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—stomach cancer	8.52e-05	0.00037	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPAP2A—stomach cancer	8.32e-05	0.000361	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—MAPK3—stomach cancer	8.31e-05	0.000361	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	8.3e-05	0.00036	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	8.18e-05	0.000355	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FYN—stomach cancer	8.18e-05	0.000355	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6R—stomach cancer	8.05e-05	0.00035	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	8e-05	0.000347	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PGLS—stomach cancer	7.95e-05	0.000345	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BLVRB—stomach cancer	7.95e-05	0.000345	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—MAPK1—stomach cancer	7.9e-05	0.000343	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—EGFR—stomach cancer	7.9e-05	0.000343	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACAD8—stomach cancer	7.76e-05	0.000337	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—stomach cancer	7.74e-05	0.000336	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGFR2—stomach cancer	7.68e-05	0.000333	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPAP2A—stomach cancer	7.58e-05	0.000329	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—PIK3CA—stomach cancer	7.55e-05	0.000328	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SERPINE1—stomach cancer	7.54e-05	0.000327	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—KRAS—stomach cancer	7.47e-05	0.000324	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FBP1—stomach cancer	7.41e-05	0.000322	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CA1—stomach cancer	7.41e-05	0.000322	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NDUFA2—stomach cancer	7.41e-05	0.000322	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CKB—stomach cancer	7.41e-05	0.000322	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.29e-05	0.000317	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RHOA—stomach cancer	7.28e-05	0.000316	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—stomach cancer	7.2e-05	0.000313	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IRS2—stomach cancer	7.03e-05	0.000305	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLIN2—stomach cancer	6.97e-05	0.000303	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GMPR2—stomach cancer	6.92e-05	0.0003	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—PIK3CA—stomach cancer	6.86e-05	0.000298	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CAV1—stomach cancer	6.82e-05	0.000296	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOA1—stomach cancer	6.8e-05	0.000295	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CA2—stomach cancer	6.78e-05	0.000294	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FBP1—stomach cancer	6.76e-05	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CA1—stomach cancer	6.76e-05	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NDUFA2—stomach cancer	6.76e-05	0.000293	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CKB—stomach cancer	6.76e-05	0.000293	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ERBB2—stomach cancer	6.73e-05	0.000292	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NT5E—stomach cancer	6.61e-05	0.000287	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PGAM1—stomach cancer	6.61e-05	0.000287	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRKCB—stomach cancer	6.49e-05	0.000282	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6ST—stomach cancer	6.46e-05	0.000281	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—stomach cancer	6.39e-05	0.000277	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLIN2—stomach cancer	6.35e-05	0.000276	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HRAS—stomach cancer	6.35e-05	0.000275	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—IDH3B—stomach cancer	6.33e-05	0.000275	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SUCLG1—stomach cancer	6.33e-05	0.000275	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLCE1—stomach cancer	6.3e-05	0.000274	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDH7A1—stomach cancer	6.3e-05	0.000274	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN1B—stomach cancer	6.24e-05	0.000271	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APC—stomach cancer	6.21e-05	0.00027	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CA2—stomach cancer	6.18e-05	0.000268	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—stomach cancer	6.07e-05	0.000264	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—UMPS—stomach cancer	6.04e-05	0.000262	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NT5E—stomach cancer	6.02e-05	0.000262	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PGAM1—stomach cancer	6.02e-05	0.000262	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCND1—stomach cancer	5.95e-05	0.000258	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MAPK3—stomach cancer	5.95e-05	0.000258	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JUN—stomach cancer	5.94e-05	0.000258	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NDUFV1—stomach cancer	5.88e-05	0.000255	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NDUFS1—stomach cancer	5.88e-05	0.000255	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—stomach cancer	5.78e-05	0.000251	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6R—stomach cancer	5.76e-05	0.00025	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN1A—stomach cancer	5.76e-05	0.00025	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLCE1—stomach cancer	5.75e-05	0.00025	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDH7A1—stomach cancer	5.75e-05	0.00025	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MAPK1—stomach cancer	5.66e-05	0.000246	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—stomach cancer	5.66e-05	0.000246	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK8—stomach cancer	5.62e-05	0.000244	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ECHS1—stomach cancer	5.62e-05	0.000244	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PDHA1—stomach cancer	5.62e-05	0.000244	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—UMPS—stomach cancer	5.51e-05	0.000239	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CA—stomach cancer	5.41e-05	0.000235	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—stomach cancer	5.4e-05	0.000234	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—KRAS—stomach cancer	5.34e-05	0.000232	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TYMP—stomach cancer	5.28e-05	0.000229	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FADS1—stomach cancer	5.28e-05	0.000229	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BLVRB—stomach cancer	5.24e-05	0.000228	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PGLS—stomach cancer	5.24e-05	0.000228	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RHOA—stomach cancer	5.21e-05	0.000226	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—stomach cancer	5.19e-05	0.000225	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—stomach cancer	5.15e-05	0.000224	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—stomach cancer	5.14e-05	0.000223	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PDHA1—stomach cancer	5.12e-05	0.000222	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ECHS1—stomach cancer	5.12e-05	0.000222	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPAP2A—stomach cancer	5e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SREBF2—stomach cancer	4.95e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CA—stomach cancer	4.91e-05	0.000213	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK3—stomach cancer	4.91e-05	0.000213	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—RORA—stomach cancer	4.89e-05	0.000212	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ERBB2—stomach cancer	4.82e-05	0.000209	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FADS1—stomach cancer	4.82e-05	0.000209	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TYMP—stomach cancer	4.82e-05	0.000209	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MYC—stomach cancer	4.77e-05	0.000207	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK1—stomach cancer	4.67e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—stomach cancer	4.67e-05	0.000203	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDOB—stomach cancer	4.58e-05	0.000199	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—stomach cancer	4.57e-05	0.000198	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HRAS—stomach cancer	4.54e-05	0.000197	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SREBF2—stomach cancer	4.51e-05	0.000196	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN1B—stomach cancer	4.46e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FBP1—stomach cancer	4.46e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.46e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CKB—stomach cancer	4.46e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CA1—stomach cancer	4.46e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—RORA—stomach cancer	4.46e-05	0.000193	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KRAS—stomach cancer	4.41e-05	0.000191	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—stomach cancer	4.35e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.32e-05	0.000187	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.31e-05	0.000187	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCND1—stomach cancer	4.26e-05	0.000185	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5—stomach cancer	4.26e-05	0.000185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JUN—stomach cancer	4.25e-05	0.000184	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLIN2—stomach cancer	4.19e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DPYD—stomach cancer	4.19e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDOB—stomach cancer	4.18e-05	0.000181	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—stomach cancer	4.13e-05	0.00018	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN1A—stomach cancer	4.12e-05	0.000179	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CA2—stomach cancer	4.08e-05	0.000177	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CA—stomach cancer	4.05e-05	0.000176	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK8—stomach cancer	4.02e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PGAM1—stomach cancer	3.97e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NT5E—stomach cancer	3.97e-05	0.000172	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.94e-05	0.000171	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.93e-05	0.000171	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—stomach cancer	3.92e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5—stomach cancer	3.88e-05	0.000169	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DPYD—stomach cancer	3.82e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.8e-05	0.000165	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLCE1—stomach cancer	3.79e-05	0.000165	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.79e-05	0.000165	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HRAS—stomach cancer	3.75e-05	0.000163	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—stomach cancer	3.71e-05	0.000161	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—stomach cancer	3.7e-05	0.000161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—stomach cancer	3.68e-05	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.66e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—UMPS—stomach cancer	3.63e-05	0.000158	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—stomach cancer	3.59e-05	0.000156	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.56e-05	0.000155	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK3—stomach cancer	3.51e-05	0.000152	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO1—stomach cancer	3.47e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.46e-05	0.00015	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MYC—stomach cancer	3.42e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.41e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PDHA1—stomach cancer	3.38e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ECHS1—stomach cancer	3.38e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—stomach cancer	3.38e-05	0.000147	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK1—stomach cancer	3.34e-05	0.000145	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—stomach cancer	3.34e-05	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.34e-05	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKR1C3—stomach cancer	3.25e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FADS1—stomach cancer	3.18e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TYMP—stomach cancer	3.18e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO1—stomach cancer	3.16e-05	0.000137	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KRAS—stomach cancer	3.16e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.11e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CD44—stomach cancer	3.08e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.99e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SREBF2—stomach cancer	2.97e-05	0.000129	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—RORA—stomach cancer	2.94e-05	0.000128	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CA—stomach cancer	2.9e-05	0.000126	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CD44—stomach cancer	2.81e-05	0.000122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—stomach cancer	2.81e-05	0.000122	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDOB—stomach cancer	2.75e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.72e-05	0.000118	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HRAS—stomach cancer	2.68e-05	0.000116	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.62e-05	0.000114	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—stomach cancer	2.57e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTP1—stomach cancer	2.57e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5—stomach cancer	2.56e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—stomach cancer	2.53e-05	0.00011	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DPYD—stomach cancer	2.52e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TYMS—stomach cancer	2.39e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.39e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—stomach cancer	2.36e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTP1—stomach cancer	2.34e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—stomach cancer	2.31e-05	0.0001	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—stomach cancer	2.23e-05	9.67e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ERCC2—stomach cancer	2.22e-05	9.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.2e-05	9.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TYMS—stomach cancer	2.18e-05	9.45e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—stomach cancer	2.15e-05	9.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.14e-05	9.3e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO1—stomach cancer	2.09e-05	9.06e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—stomach cancer	2.08e-05	9.05e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ERCC2—stomach cancer	2.02e-05	8.78e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAV1—stomach cancer	1.92e-05	8.35e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA1—stomach cancer	1.92e-05	8.33e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—stomach cancer	1.9e-05	8.25e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CD44—stomach cancer	1.85e-05	8.04e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.84e-05	7.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAV1—stomach cancer	1.75e-05	7.61e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA1—stomach cancer	1.75e-05	7.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—stomach cancer	1.69e-05	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.68e-05	7.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.57e-05	6.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTP1—stomach cancer	1.54e-05	6.7e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—stomach cancer	1.54e-05	6.69e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—stomach cancer	1.52e-05	6.61e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—stomach cancer	1.52e-05	6.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—stomach cancer	1.45e-05	6.31e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TYMS—stomach cancer	1.44e-05	6.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—stomach cancer	1.42e-05	6.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—stomach cancer	1.39e-05	6.02e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ERCC2—stomach cancer	1.33e-05	5.79e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—stomach cancer	1.33e-05	5.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—stomach cancer	1.33e-05	5.76e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—stomach cancer	1.25e-05	5.44e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—stomach cancer	1.21e-05	5.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAV1—stomach cancer	1.16e-05	5.02e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA1—stomach cancer	1.15e-05	5.01e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—stomach cancer	1.02e-05	4.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—stomach cancer	9.14e-06	3.97e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—stomach cancer	8.74e-06	3.8e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CA—stomach cancer	8.18e-06	3.55e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—stomach cancer	8e-06	3.47e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CA—stomach cancer	7.46e-06	3.24e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.92e-06	2.14e-05	CbGpPWpGaD
